SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-048025
Filing Date
2023-09-13
Accepted
2023-09-13 21:31:18
Documents
2
Period of Report
2023-09-11

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 6617
2 EX-24 dnth-ex24.htm EX-24 9668
  Complete submission text file 0000950170-23-048025.txt   18324
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Issuer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2828 N HARWOOD STREET SUITE 1220 DALLAS TX 75201
Business Address 2828 N HARWOOD STREET SUITE 1220 DALLAS TX 75201 214-550-1822
Avidity Partners Management LP (Reporting) CIK: 0001791827 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38541 | Film No.: 231253924

Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address
Meng Lei (Reporting) CIK: 0001992281 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38541 | Film No.: 231253925